Get startedLog in
    Picture of China Medical System Holdings logo

    867 — China Medical System Holdings News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: China Medical System Gets Acceptance From China's NMPA For New Drug Application Of Ruxolitinib Phosphate Cream For Treatment Of Atopic Dermatitis

    Picture of China Medical System Holdings logoChina Medical System Holdings
    24/02/2026 10:26
    Feb 24 (Reuters) - China Medical System Holdings Ltd 0867.HK:

GETS ACCEPTANCE FROM CHINA'S NMPA FOR NEW DRUG APPLICATION OF RUXOLITINIB PHOSPHATE CREAM FOR TREATMENT OF ATOPIC DERMATITIS

Further company coverage: 0867.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on China Medical System Holdings

    See all news